Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014

Morbidity and Mortality Weekly Report

Volumn 63, Issue 7, 2014, Pages 137-142

  Flannery, Brendan ^a   Thaker, Swathi N ^a   Clippard, Jessie ^a   Monto, Arnold S ^b   Ohmit, Suzanne E ^b   Zimmerman, Richard K ^c   Nowalk, Mary Patricia ^c   Gaglani, Manjusha ^d   Jackson, Michael L ^e   Jackson, Lisa A ^e   Belongia, Edward A ^f   Mclean, Huong Q ^f   Berman, Lashondra ^a   Foust, Angie ^a   Sessions, Wendy ^a   Spencer, Sarah ^a   Fry, Alicia M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d TEXAS A M COLLEGE OF MEDICINE   (United States)

^e GROUP HEALTH RESEARCH INSTITUTE   (United States)

^f MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOLOGY; INFANT; INFLUENZA; INFLUENZA VIRUS A H1N1; MALE; MIDDLE AGED; NOTE; PRESCHOOL CHILD; SEASON; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; SEASONS; UNITED STATES; YOUNG ADULT;

EID: 84894280010     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. CDC. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2012-13 influenza season. MMWR 2012;61:613-618.
2. CDC. Update: influenza activity-United States, September 29, 2013- February 8, 2014. MMWR 2014;63:148-54.
3. CDC. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2011;60(No. RR-1).
4. Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014;58:319-327.
5. Griffin MR, Monto AS, Belongia EA, et al. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One 2011;6:e23085.
6. Bateman AC, Kieke BA, Irving SA, Meece JK, Shay DK, Belongia EA. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season. J Infect Dis 2013;207:1262-1269.
7. Treanor JJ, Talbot HK, Ohmit SE, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012;55:951-959.
8. Skowronski DM, Chambers C, Sabaiduc S, et al. Interim estimates of 2013/14 vaccine effectiveness against influenza A (H1N1)pdm09 from Canada's sentinel surveillance network, January 2014. Euro Surveill 2014;19(5).
9. Thompson MG, Li DK, Shifflett P, et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis 2014;58:449-457.
10. De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill 2013;18:20585.